Page results
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
This is information for women who have been given a diagnosis of adenomyosis.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Bones marrow harvest patient information page.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
File results
-
FOI/2023/0917 - Patient Initiated Digital Mutual Aid System (PIDMAS)
-
FOI/2023/0921 - Trust provider for sexual health platform
-
FOI/2023/0923 - Proton Beam Therapy treatments
-
FOI/2023/0925 - Stereotactic radiosurgery treatment/ gamma knife treatment
-
FOI/2023/0926 - Electronic Patient Record Supplier (EPR) contract
-
FOI/2023/0930 - Patient deaths while on waiting list 2018-2023
-
FOI/2023/0931 - Trust surgical and equipment drape usage in theatre departments
-
FOI/2023/0934 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0936 - Policy and Procedure management at Trust
-
FOI/2023/0938 - Trust pain management education provided to staff